UPL Ltd Q3 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/j8m2eiclldzwtpe3vraabcc9.pdf

Key Takeaways


The Destocking Cycle: Where the Pain Is, and Where It Is Easing

Mike Frank: "We would expect the price challenges to continue at least in the early part of next year. And so that will be similar to this year, but some of the underlying impacts that we dealt with this year should be behind us."

Margin Mechanics: Transitory Damage vs. Structural Reset

Rajendra Darak: "Just to give you a data point on our top 15 molecules, if we take the cost of UPL as of the latest cost of production, the latest China price, on an average UPL is 15% plus competitive versus China today."

Balance Sheet & the Rights Issue

Anand Vora: "Clearly, if one has just look at the numbers of our net debt as well as EBITDA, it's going to be challenging to retain our investment grade."

China, Pricing & Competitive Position

Mike Frank: "we can see that in essence, they're selling at or near their variable cost. And so, there's not a lot of space at this point in the post-patent segment for the market to decline any further"

Portfolio Moves & the Recovery Playbook


Guidance & Commitments

CommitmentSpecificsTimeline
Full-year FY24 revenueLower by 18-20% vs FY23FY24
Full-year FY24 EBITDALower by 45-50% vs FY23FY24
Full-year FY24 net lossAround ₹1,200-1,400 croresFY24
Sequential margin recoveryNet positive EBITDA and greater margins in Q4 vs Q3Q4 FY24
High-cost inventory clearancePath to clear as exiting FY24; very little impact entering FY25FY24 exit / FY25 start
SG&A reduction$100 million reduction vs FY23 baseFY25
Net debt target (operating)Around $2.5 billionQ4 FY24
Rights issue announcementUp to $500 millionBefore end of February 2024
Channel inventory normalizationLatAm ex-Brazil in Q4; NA, Europe, Brazil over next few quartersQ4 FY24 and beyond
Distributor restockingExpected to beginMid-calendar 2024
India glufosinate demand recoveryExpected to recoverComing Kharif season
CapexFull year likely $250 millionFY24

Key Metrics

MetricQ3 FY24
RevenueDown 28% YoY; pro forma revenue ₹10,695 cr, down 22% YoY
EBITDA₹416 cr, down 86% YoY
Net loss₹1,217 cr, driven by one-time contribution impact of ₹1,532 cr and FX loss of ₹256 cr from Argentina devaluation
Contribution marginContracted 15% YoY; pro forma margin lower by only 3% YoY after adjusting for transitory rebates and returns
SG&A expenseDown 19% YoY; on track for $100 million reduction in FY25 vs FY23 base
Net finance cost₹716 cr, down from ₹732 cr YoY
FX loss₹613 cr, including ₹297 cr from Argentinian Peso devaluation
Net debt$3.77 bn, up $439 mn YoY; payables down $568 mn YoY
Working capital days155 days, increased 34 days YoY
Differentiated & sustainable portfolio share32% of crop protection revenue, up from 29% YoY; 37% of volumes
Brazil market share9.1%, up from 8.5% in 2023
Advanta (seeds) revenue growth11% in 9M FY24
UPL SAS (India) revenueDown 34% YoY; EBITDA down 47%
Full-year FY24 revenue guidanceDown 18–20% vs FY23
Full-year FY24 EBITDA guidanceDown 45–50% vs FY23